In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …

Cancer and autoimmune disease are closely related, and many therapeutic antibodies are
widely used in clinics for the treatment of both diseases. Among them, the anti-CD20 …

Nanomedicines achieve tumor-targeted delivery mainly through enhanced permeability and
retention (EPR) effect following intravenous (IV) administration. Unfortunately, the EPR effect …

Background Peritoneal carcinomatosis is a fatal clinical presentation of colon cancer,
characterized by unresponsiveness to conventional anticancer therapies, including immune …

The dissemination of tumor metastasis in the peritoneal cavity, also called peritoneal
metastasis (PM) or carcinomatosis, represents a late stage of gastrointestinal and …

Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …

Abstract Background Pressurized Intraperitoneal Aerosol chemotherapy (PIPAC) is a local
treatment for peritoneal metastasis (PM). Prospective data are scarce and evaluation of …

Peritoneal metastasis (PM) is considered as the terminal stage of metastatic colon cancer,
with still poor median survival rate even with the best recent chemotherapy treatment. The …

Gastric cancer (GC) is a leading cause of worldwide cancer-related death. Being a highly
heterogeneous disease, the current treatment of GC has been suboptimal due to the lack of …

Latest advances in the field of cancer immunotherapy have developed the (Chimeric
Antigen Receptor) CAR-T cell therapy. This therapy was first used in hematological …